ARTICLE | Clinical News
Darvon-N propoxyphene regulatory update
December 13, 2010 8:00 AM UTC
Paladin will recall and withdraw all lots of pain drug Darvon-N propoxyphene from the Canadian market and discontinue the sale of the product. Paladin said the decision follows FDA's request to withdr...